Werewolf Therapeutics, Inc.
Records under this name other than the patents Werewolf Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.
Back to Werewolf Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| 17/028,643 | Activatable Cytokine Polypeptides and Methods of Use Thereof Abandoned Abandoned Mar 19, 2026 | Abandoned | Abandoned Mar 19, 2026 | |
| 17/082,955 | Separation Moieties and Methods of Use Thereof now held by EMD Serono, Inc. Abandoned Abandoned Sep 23, 2026 | Abandoned | Abandoned Sep 23, 2026 | |
| 17/741,275 | Activatable Cytokine Polypeptides and Methods of Use Thereof held by EMD Serono, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/054,601 | Activatable IL-12 Polypeptides and Methods of Use Thereof held by EMD Serono, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/312,245 | Activatable Cytokine Polypeptides and Methods of Use Thereof now held by EMD Serono, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/315,927 | Separation Moieties and Methods of Use Thereof held by EMD Serono, Inc. Abandoned Abandoned Oct 21, 2026 | Abandoned | Abandoned Oct 21, 2026 | |
| 18/440,775 | Inducible IL-2 and PD-1/PD-L1 Combination Therapy Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/440,816 | Inducible Cytokine Prodrug and PD-1/PD-L1 Combination Therapy held by EMD Serono, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/440,841 | Activatable Interferon Polypeptides and Methods of Use Thereof held by EMD Serono, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/626,430 | IL-2 Prodrug held by EMD Serono, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. |